PPA
EPZM

Parametric Portfolio Associates’s Epizyme, Inc EPZM Stock Holding History

Parametric Portfolio Associates’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$28K Sell
24,475
-110,449
-82% -$180K ﹤0.01% 3654
2021
Q4 		$337K Buy
134,924
+69,471
+106% +$273K ﹤0.01% 3236
2021
Q3 		$335K Buy
65,453
+7,831
+14% +$47.6K ﹤0.01% 3258
2021
Q2 		$479K Buy
57,622
+18,332
+47% +$155K ﹤0.01% 3105
2021
Q1 		$342K Buy
39,290
+15,678
+66% +$162K ﹤0.01% 3668
2020
Q4 		$256K Buy
23,612
+5,394
+30% +$66.5K ﹤0.01% 3673
2020
Q3 		$217K Sell
18,218
-31,831
-64% -$426K ﹤0.01% 3624
2020
Q2 		$804K Sell
50,049
-21,674
-30% -$378K ﹤0.01% 3037
2020
Q1 		$1.11M Sell
71,723
-1,100
-2% -$23.6K ﹤0.01% 2746
2019
Q4 		$1.79M Buy
+72,823
New +$1.08M ﹤0.01% 2760

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parametric Portfolio Associates's EPZM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Epizyme, Inc (EPZM) stake by 82% in Q1 2022, selling an estimated $180K and leaving 24,475 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #3654.

Parametric Portfolio Associates first reported a position in EPZM in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.79M in Q4 2019. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • Parametric Portfolio Associates held 24,475 shares of Epizyme, Inc worth $28K as of Q1 2022.
  • Parametric Portfolio Associates sold 110,449 Epizyme, Inc shares in Q1 2022, an estimated $180K.
  • Epizyme, Inc made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3654 holding.
  • Parametric Portfolio Associates first reported a position in Epizyme, Inc in Q4 2019 and has held it in 10 quarters since.
  • Parametric Portfolio Associates's Epizyme, Inc position peaked at $1.79M in Q4 2019.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.